Issues related to the development, testing, and approval of pharmaceutical products.
2026 · 2nd Quarter (Apr 1 - June 30)
CURIE BIO OPERATIONS, LLC
Filed by MARSHALL & POPP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Termination
- Posted
- Jul 9, 2026
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- MARSHALL & POPP, LLC
- Filing UUID
- 61719194-48a1-4cca-854c-3dba6389ce86
- Termination date
- Jun 1, 2026
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.